A 77-year-old woman with CKD gets IV furosemide for heart failure. Now she can't hear. The pump you blocked in her kidney also runs in her ear.
Clinical Vignette
A 77-year-old woman with CKD stage IV is admitted for acute decompensated heart failure. She receives IV furosemide. Two days later she reports bilateral hearing loss. Audiometry shows sensorineural hearing loss. Which mechanism best explains this adverse effect?
Scroll to learn why the kidney and the ear share a pump
Tap a segment to see which diuretic lives there
👁
The High-Yield Detail · Loop Diuretic Ototoxicity
WHY YOU GOT IT WRONG
Here's the connection that makes this click forever:
Your kidney's thick ascending limbThe TAL reabsorbs ~25% of filtered sodium using the Na-K-2Cl cotransporter (NKCC2). This is the most powerful reabsorption site after the PCT, which is why blocking it causes massive diuresis. uses a pump called NKCC2 to move Na+, K+, and 2Cl- from the tubular lumen into the cell. Furosemide blocks this pump. That's how it makes you pee.
Your inner ear's stria vascularisThe stria vascularis is a specialized tissue in the lateral wall of the cochlear duct. It maintains the endolymph's unusually high potassium concentration (+80 mV endocochlear potential) that hair cells need to transduce sound into nerve signals. uses a nearly identical pump called NKCC1 to maintain the endocochlear potential · the +80 mV electrical gradient that hair cells need to convert sound waves into nerve signals.
The High-Yield DetailSame family of pumps. Two completely different organs. Block NKCC2 in the kidney → you pee. Block NKCC1 in the ear → the endocochlear potential drops → hair cells stop transducing sound → sensorineural hearing loss.
🔑
The ear is basically a tiny nephron. Same pump, different address. Furosemide doesn't know which one it's blocking.
Why CKD makes it worse: If the kidneys can't clear furosemide efficiently, the drug accumulates in the blood. Higher blood levels mean more drug reaching the stria vascularis. CKD + high-dose IV furosemide = the perfect storm for ototoxicity.
Risk Factors for Loop Diuretic OtotoxicityHigh IV dose (especially rapid infusion) + renal failure (can't clear the drug) + concurrent aminoglycosides (also ototoxic via hair cell damage). Ethacrynic acid is the worst offender. Usually reversible if caught early, but can be permanent.
Why Carbonic Anhydrase Inhibitors Were Wrong
Acetazolamide works in the PCT, not the ear. It causes metabolic acidosis, not hearing loss. It's used for glaucoma and altitude sickness · neither of which has anything to do with acute decompensated heart failure. If the stem says "heart failure" and "IV diuretic," you're in loop territory, not CA inhibitor territory.
💧
Proximal Tubule · Carbonic Anhydrase Inhibitors
PCT
The PCT reabsorbs 65-80% of filtered sodium and water. The enzyme carbonic anhydraseCO2 + H2O ↔ H2CO3 ↔ H+ + HCO3-. In the PCT, this lets the tubule reclaim filtered bicarbonate by converting it to CO2 (which crosses membranes freely), then reconverting inside the cell. Block the enzyme = bicarb pours out in the urine. is the middleman that reclaims bicarbonate.
The DrugAcetazolamide · blocks carbonic anhydrase. Bicarb can't be reabsorbed → non-anion gap metabolic acidosis + alkaline urine (that's where the bicarb went).
🔑
Acetazolamide = Acidosis. The A's match. And the paradox: the patient is acidotic but the urine is basic.
Side effects: Metabolic acidosis, hypokalemia, calcium phosphate kidney stones (alkaline urine shifts stone composition from the usual oxalate to phosphate).
🌊
PCT + Descending Loop · Osmotic Diuretics
MANNITOL
Mannitol is a sugar that gets filtered by the glomerulus but not reabsorbed. It sits in the tubule and holds water by osmotic force. Think of it as a sponge that refuses to leave the pipe · water follows it all the way out.
Where It Works
Primarily the PCT and descending loop of Henle · the water-permeable segments. Doesn't block any transporter. Just pulls water into the tubule by being there.
Uses:Cerebral edema (IV mannitol pulls water out of brain tissue into the vasculature), elevated intraocular pressure, drug overdose (forced diuresis).
Danger: Can cause pulmonary edema if you give it to a patient who can't handle the initial volume expansion (it pulls fluid into the vascular space before the kidneys excrete it). Contraindicated in CHF and anuria.
🔥
Thick Ascending Limb · Loop Diuretics
THE BIG GUNS
The TAL reabsorbs ~25% of filtered Na+ via NKCC2 (Na-K-2Cl cotransporter). This is also where the kidney builds the medullary concentration gradient that lets the collecting duct concentrate urine. Block NKCC2 and you destroy both · massive Na+ loss AND the kidney can't concentrate urine anymore.
The DrugsFurosemide (Lasix), bumetanide (40x more potent mg-for-mg), torsemide, ethacrynic acid (the only non-sulfonamide loop).
🔑
Loops Lose Lots. And: ethacrynic = "ethacryn-no-sulfa" · the one you use in sulfa allergy.
Electrolyte carnage:
What's Lost
Why
Na+
Direct · NKCC2 is blocked, so Na+ stays in the lumen
K+
More Na+ delivered distally → more Na/K exchange at CD → K+ wasting
Ca2+
The TAL normally reabsorbs Ca2+ via paracellular channels driven by lumen-positive voltage from K+ recycling. Block NKCC2 → lose the voltage → Ca2+ pours out
Uses: Acute pulmonary edema (IV furosemide works in minutes), CHF volume overload, hypercalcemia (loops waste calcium), acute kidney injury.
Ethacrynic acid · the oddball: Only loop that is not a sulfonamide. Use it in sulfa allergy. Tradeoff: the most ototoxic of the bunch.
The Calcium Trap (Tested Every Year)Loops LOSE calcium (hypocalcemia). Thiazides TRAP calcium (hypercalcemia). This is the single most tested diuretic comparison in clinical practice. If you remember nothing else from this page, remember this.
🔑
Loops Lose calcium. Thiazides Trap calcium. L for Lose. T for Trap.
Why the Ear Is Collateral Damage
The stria vascularis uses NKCC1 (same family as kidney's NKCC2) to pump K+ into the endolymph. This maintains the +80 mV endocochlear potential that hair cells need. Block the pump → potential drops → hair cells go silent.
💊
Early DCT · Thiazide Diuretics
THE MAINTENANCE DRUG
The DCT reabsorbs only ~5% of filtered Na+ via the NCC (Na-Cl cotransporter)Simpler than NKCC2 · just Na+ and Cl-. No K+, no voltage games. Blocking NCC is a gentler diuresis than blocking NKCC2. That's why thiazides are maintenance drugs and loops are rescue drugs.. Weaker than loops, but they shine in chronic management.
The DrugsHCTZ, chlorthalidone (longer acting, preferred for HTN), metolazone (works even in low GFR · synergizes with loops for diuretic resistance).
The calcium twist: Thiazides increase calcium reabsorption in the DCT. Mechanism: blocking NCC → less Na+ inside the cell → the basolateral Na/Ca exchanger works harder to export Ca2+ from the cell into the blood → intracellular Ca2+ drops → apical Ca2+ channels pull more Ca2+ in from the tubular lumen. Net result: more Ca2+ ends up in the blood.
Effect
Direction
Board Relevance
Hypokalemia
↓
Same mechanism as loops · distal Na → K wasting
Hyponatremia
↓
#1 drug cause of hyponatremia in elderly
Hypercalcemia
↑
OPPOSITE of loops · thiazides save Ca2+
Hyperglycemia
↑
K+ depletion impairs insulin release from beta cells
Hyperuricemia
↑
Competes with uric acid for PCT secretion → gout
Hyperlipidemia
↑
Mild LDL and TG elevation
Hyponatremia Trap
"Elderly woman on HCTZ, confused, Na+ of 118." That's thiazide-induced hyponatremia. Not loops. Loops impair concentrating ability (dilute urine), so ADH can't trap water. Thiazides preserve the medullary gradient · ADH still works · free water gets trapped → dilutional hyponatremia.
💫
Collecting Duct · Potassium-Sparing Diuretics
SAVE THE POTASSIUM
The collecting duct is where aldosteroneAldosterone binds nuclear receptors in principal cells → upregulates ENaC (Na+ channels) on luminal side and Na/K-ATPase basolaterally. Net: Na+ reabsorbed, K+ secreted. Block aldosterone = keep K+, lose Na+. does its final Na+/K+ tuning. Two totally different drug mechanisms, same result:
Trace It
Drugs
Key Detail
Aldosterone antagonists
Spironolactone, Eplerenone
Block the aldosterone receptor → ENaC never gets upregulated
ENaC blockers
Amiloride, Triamterene
Plug the Na+ channel directly · aldosterone is irrelevant
Spironolactone ExtrasHeart failure: Reduces mortality in HFrEF (RALES trial) via anti-fibrotic, anti-remodeling effects · not for diuresis. Side effect:Gynecomastia (anti-androgen effect). Eplerenone is more selective → no gynecomastia, but pricier.
🔑
Spironolactone spins your hormones → man boobs. Eplerenone = the gentleman's version.
The danger:Hyperkalemia. Combine with ACE inhibitor + renal insufficiency = peaked T waves and cardiac arrest territory.
Amiloride special uses:Liddle syndromeGain-of-function ENaC mutation. Channel is always open, always grabbing Na+, always wasting K+. Looks like hyperaldosteronism but aldosterone is LOW. Amiloride plugs the overactive channel directly. (plugs the overactive ENaC channel) and lithium-induced nephrogenic DI (blocks lithium entry through ENaC).
💦
Collecting Duct · ADH Antagonists (Vaptans)
AQUARESIS
Tolvaptan blocks the V2 receptorADH (vasopressin) binds V2 receptors on principal cells of the collecting duct, causing aquaporin-2 insertion into the luminal membrane. Water then follows the osmotic gradient from tubule into the medullary interstitium. Block V2 = aquaporins stay in vesicles = water stays in the tubule. on the collecting duct's principal cells. Without V2 signaling, aquaporin-2 channels don't insert into the membrane. Water can't be reabsorbed. You excrete pure water · "aquaresis", not natriuresis.
Key Distinction
Other diuretics make you lose Na+ and water together. Tolvaptan makes you lose water only. That's why it treats euvolemic and hypervolemic hyponatremia (SIADH, cirrhosis, CHF) · the problem is too much water, not too much Na+.
Side effect: Too-rapid sodium correction → osmotic demyelination syndrome (central pontine myelinolysis). Check Na+ frequently. Also hepatotoxicity risk.
📈
The Full Picture
SIDE BY SIDE
Class
Site
Target
K+
Ca2+
Acid-Base
CA Inhibitors Acetazolamide
PCT
Carbonic anhydrase
↓
,
Met. Acidosis
Osmotic Mannitol
PCT + Desc.
Osmotic force
,
,
,
Loop Furosemide
TAL
NKCC2
↓
↓ loses
Met. Alkalosis
Thiazide HCTZ
DCT
NCC
↓
↑ traps
Met. Alkalosis
K-Sparing Spironolactone
CD
Aldo receptor / ENaC
↑ saves
,
Met. Acidosis
Vaptans Tolvaptan
CD
V2 receptor
,
,
,
Pattern Lock
Everything except K-sparing causes hypokalemia (more Na+ distally = more K+ wasting). Loops and thiazides both cause metabolic alkalosis (volume contraction + H+ secretion). CA inhibitors and K-sparing both cause metabolic acidosis. Loops lose calcium; thiazides trap calcium.
Hyponatremia + SIADH or euvolemic/hypervolemic state
→ Tolvaptan (V2 antagonist) Pure water out. Fix the water problem without dropping Na+ further. Correct slowly: <10-12 mEq/L per 24h.
Sulfa allergy but patient needs a loop?
Give ethacrynic acid
→ Only non-sulfonamide loop diuretic. Tradeoff: most ototoxic of the loops. Use when the allergy risk outweighs hearing risk.
Diuretic resistance on loop + thiazide?
→ Add metolazone (works even in low GFR) Sequential nephron blockade: loop blocks TAL, metolazone blocks DCT. Monitor electrolytes aggressively.
🎞
Clinical Images
REFERENCE
FurosemideLoop diuretic reference
HCTZThiazide reference
NephronSite-of-action reference
Loading images...
Which Diuretic for Which Condition?
Pick the clinical indication, follow to the right drug.
Clinical indication?
Clinical indication?
IV furosemide: loop diuretic with fast onset + venodilation effect. First-line in acute decompensated HF and pulmonary edema emergencies.
Loop diuretic (furosemide, bumetanide) for volume control. Add aldosterone antagonist (spironolactone) for mortality benefit in HFrEF (RALES trial).
Thiazide (HCTZ, chlorthalidone) first-line. Switch to loop diuretic if CrCl less than 30 (thiazides lose efficacy). Add spironolactone for resistant HTN (4th agent).
Spironolactone + furosemide combination at 100:40 ratio. Spiro targets aldosterone-driven Na retention; furosemide augments diuresis. Ratio prevents dangerous electrolyte shifts.
Loop diuretic (furosemide). Often needs high doses due to poor GI absorption and albumin binding of the drug in the tubular lumen. IV route more reliable in severe cases.
Loop diuretic (furosemide) + aggressive IV saline. Saline dilutes calcium + restores volume; furosemide promotes calciuresis by blocking NKCC2 (calcium reabsorption is coupled to sodium in the TAL). Do NOT use thiazides -- they cause hypercalcemia.
Spironolactone or eplerenone: potassium-sparing aldosterone antagonists. Block mineralocorticoid receptor in the collecting duct. Eplerenone has fewer anti-androgen side effects (no gynecomastia).
Acetazolamide: carbonic anhydrase inhibitor. Reduces CSF production by blocking bicarbonate secretion at the choroid plexus. Also causes metabolic acidosis as a side effect.
Acetazolamide: causes mild metabolic acidosis, which stimulates ventilation and compensates for the respiratory alkalosis of high altitude. Start 1-2 days before ascent.
🎯
Test Yourself
clinical
10 patients. 5 at a time. Every question is original. Every wrong answer teaches you something.
Medically reviewed by Kaitlyn Cocuzzo, MD and Fatima Ali, DO · Last updated July 1, 2026 at 10:03 PM ET
Bone Wizardry is an independent educational resource for visual learning in the medical sciences. It is not affiliated with, endorsed by, or sponsored by any licensing or examination board, contains no real or recalled examination questions, and does not guarantee any educational or examination outcome.
